Mezzion Pharma
KOSDAQ:A140410
91.000,00
+ ₩700,00 (0,78%)
91.000,00
+₩700,00 (0,78%)
End-of-day quote: 04/23/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

₩-533,67
Earnings Per Share
₩955,75
Revenue Per Share
0,00%
Gross Margin %
₩2.744,41 B
Market Cap
₩26,26 B
Long-Term Debt
Earnings Per Share
₩-533,67
Revenue Per Share
₩955,75
Gross Margin %
0,00%
Market Cap
₩2.744,41 B
Long-Term Debt
₩26,26 B

Financials

Year Year 2026 2025 2020 2019 2018
EPS Earnings Per Share ₩-531,67 ₩-531,67 ₩-895,00 ₩-757,67
Earnings Earnings ₩-15,93B ₩-14,18B ₩-23,38B ₩-19,51B
RPS Revenue Per Share ₩0,00 ₩955,75 ₩1,07k ₩724,77 ₩741,43
Revenue Revenue ₩0,00M ₩28,63B ₩28,63B ₩18,93B ₩19,09B
OCF Operating Cash Flow ₩0,00M ₩-7,38B ₩-7,38B ₩-20,88B ₩-21,72B
FCF Free Cash Flow ₩0,00M ₩0,00M ₩-8,15B ₩-21,95B ₩-21,94B
OM Operating Margin 0,00% 0,00% -26,30% -136,62% -114,87%
GM % Gross Margin % 0,00% 0,00% 25,98% 16,19% 16,96%
FCFS Free Cash Flow Per Share ₩0,00 ₩0,00 ₩-589,66 ₩-846,15 ₩-894,77
LT Debt Long-Term Debt N/A N/A N/A N/A N/A
Sha. Stocks 29,96M 29,96M 26,68M 26,12M 25,75M
×